FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2053278417> ?p ?o ?g. }

• W2053278417 endingPage "5910" @default.
• W2053278417 startingPage "5904" @default.
• W2053278417 abstract "Vaccines to large B cell lymphoma were made by the covalent attachment of an epitope from the gp70 glycoprotein (SSWDFITV) to the N-termini of the conformationally biased, response-selective C5a agonists EP54 (YSFKPMPLaR) and EP67 (YSFKDMP(MeL)aR). Syngeneic Balb/c mice were immunized with these EP54/EP67-containing vaccines and challenged with a lethal dose of the highly liver metastatic and gp70-expressing lymphoma cell line RAW117-H10 to evaluate the ability of these vaccines to induce protective immune outcomes. All mice immunized with SSWDFITVRRYSFKPMPLaR (Vaccine 2) and SSWDFITVRRYSFKDMP(MeL)aR (Vaccine 3) were protected to a lethal challenge of RAW117-H10 lymphoma (>170 days survival) and exhibited no lymphoma infiltration or solid tumor nodules in the liver relative to unvaccinated controls (<18 days survival). Vaccines 2 and 3 contained the protease-sensitive double-Arg (RR) linker sequence between the epitope and the EP54/EP67 moieties in order to provide a site for intracellular proteases to separate the epitope from the EP54/EP67 moieties once internalized by the APC and, consequently, enhance epitope presentation in the context of MHC I/II. These protected mice exhibited an immune outcome consistent with increased involvement of CD8+ and/or CD4+ T lymphocytes relative to controls and mice that did not survive or showed low survival rates as with Vaccines 1 and 4, which lacked the RR linker sequence. CD8+ T lymphocytes activated in response to Vaccines 2 and 3 express cytotoxic specificity for gp70-expressing RAW117-H10 lymphoma cells, but not antigen-irrelevant MDA-MB231A human breast cancer cells. Results are discussed against the backdrop of the ability of EP54/EP67 to selectively target antigens to and activate C5a receptor-bearing antigen presenting cells and the prospects of using such vaccines therapeutically against lymphoma and other cancers." @default.
• W2053278417 created "2016-06-24" @default.
• W2053278417 creator A5044405808 @default.
• W2053278417 creator A5067292776 @default.
• W2053278417 creator A5069447727 @default.
• W2053278417 creator A5075164788 @default.
• W2053278417 creator A5079540371 @default.
• W2053278417 date "2011-08-01" @default.
• W2053278417 modified "2023-09-23" @default.
• W2053278417 title "Tumor-specific peptide-based vaccines containing the conformationally biased, response-selective C5a agonists EP54 and EP67 protect against aggressive large B cell lymphoma in a syngeneic murine model" @default.
• W2053278417 cites W1939471886 @default.
• W2053278417 cites W1973220865 @default.
• W2053278417 cites W1975497568 @default.
• W2053278417 cites W1979402582 @default.
• W2053278417 cites W2003400131 @default.
• W2053278417 cites W2004868467 @default.
• W2053278417 cites W2028932918 @default.
• W2053278417 cites W2041206065 @default.
• W2053278417 cites W2054732723 @default.
• W2053278417 cites W2076862308 @default.
• W2053278417 cites W2081135379 @default.
• W2053278417 cites W2105667065 @default.
• W2053278417 cites W2112249032 @default.
• W2053278417 cites W2116941797 @default.
• W2053278417 cites W2118965097 @default.
• W2053278417 cites W2134179828 @default.
• W2053278417 cites W2138733343 @default.
• W2053278417 cites W2154203858 @default.
• W2053278417 cites W2167172107 @default.
• W2053278417 cites W2169571221 @default.
• W2053278417 cites W2188242522 @default.
• W2053278417 cites W3091948925 @default.
• W2053278417 doi "https://doi.org/10.1016/j.vaccine.2011.06.070" @default.
• W2053278417 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21723901" @default.
• W2053278417 hasPublicationYear "2011" @default.
• W2053278417 type Work @default.
• W2053278417 sameAs 2053278417 @default.
• W2053278417 citedByCount "15" @default.
• W2053278417 countsByYear W20532784172012 @default.
• W2053278417 countsByYear W20532784172014 @default.
• W2053278417 countsByYear W20532784172015 @default.
• W2053278417 countsByYear W20532784172016 @default.
• W2053278417 countsByYear W20532784172020 @default.
• W2053278417 countsByYear W20532784172021 @default.
• W2053278417 countsByYear W20532784172022 @default.
• W2053278417 countsByYear W20532784172023 @default.
• W2053278417 crossrefType "journal-article" @default.
• W2053278417 hasAuthorship W2053278417A5044405808 @default.
• W2053278417 hasAuthorship W2053278417A5067292776 @default.
• W2053278417 hasAuthorship W2053278417A5069447727 @default.
• W2053278417 hasAuthorship W2053278417A5075164788 @default.
• W2053278417 hasAuthorship W2053278417A5079540371 @default.
• W2053278417 hasConcept C147483822 @default.
• W2053278417 hasConcept C153911025 @default.
• W2053278417 hasConcept C154317977 @default.
• W2053278417 hasConcept C159047783 @default.
• W2053278417 hasConcept C167672396 @default.
• W2053278417 hasConcept C195616568 @default.
• W2053278417 hasConcept C202751555 @default.
• W2053278417 hasConcept C203014093 @default.
• W2053278417 hasConcept C22070199 @default.
• W2053278417 hasConcept C2776090121 @default.
• W2053278417 hasConcept C2779338263 @default.
• W2053278417 hasConcept C55493867 @default.
• W2053278417 hasConcept C83464605 @default.
• W2053278417 hasConcept C86803240 @default.
• W2053278417 hasConcept C8891405 @default.
• W2053278417 hasConceptScore W2053278417C147483822 @default.
• W2053278417 hasConceptScore W2053278417C153911025 @default.
• W2053278417 hasConceptScore W2053278417C154317977 @default.
• W2053278417 hasConceptScore W2053278417C159047783 @default.
• W2053278417 hasConceptScore W2053278417C167672396 @default.
• W2053278417 hasConceptScore W2053278417C195616568 @default.
• W2053278417 hasConceptScore W2053278417C202751555 @default.
• W2053278417 hasConceptScore W2053278417C203014093 @default.
• W2053278417 hasConceptScore W2053278417C22070199 @default.
• W2053278417 hasConceptScore W2053278417C2776090121 @default.
• W2053278417 hasConceptScore W2053278417C2779338263 @default.
• W2053278417 hasConceptScore W2053278417C55493867 @default.
• W2053278417 hasConceptScore W2053278417C83464605 @default.
• W2053278417 hasConceptScore W2053278417C86803240 @default.
• W2053278417 hasConceptScore W2053278417C8891405 @default.
• W2053278417 hasIssue "35" @default.
• W2053278417 hasLocation W20532784171 @default.
• W2053278417 hasLocation W20532784172 @default.
• W2053278417 hasOpenAccess W2053278417 @default.
• W2053278417 hasPrimaryLocation W20532784171 @default.
• W2053278417 hasRelatedWork W1578871315 @default.
• W2053278417 hasRelatedWork W1618908972 @default.
• W2053278417 hasRelatedWork W1988241479 @default.
• W2053278417 hasRelatedWork W2001342405 @default.
• W2053278417 hasRelatedWork W2023982829 @default.
• W2053278417 hasRelatedWork W2052483994 @default.
• W2053278417 hasRelatedWork W2801946978 @default.
• W2053278417 hasRelatedWork W2821255169 @default.
• W2053278417 hasRelatedWork W2981642747 @default.
• W2053278417 hasRelatedWork W4254282151 @default.
• W2053278417 hasVolume "29" @default.

• next